TELMISARTAN AND AMLODIPINE

TELMISARTAN AND AMLODIPINE was reported 100 times

TELMISARTAN AND AMLODIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL TENSION GLAUCOMA 2 0.0172
1 HYPERGASTRINAEMIA 2 0.0163
2 AQUAGENIC PRURITUS 1 0.0122
3 PRECANCEROUS MUCOSAL LESION 1 0.0122
4 ANAL FUNGAL INFECTION 1 0.0120
5 KOEBNER PHENOMENON 1 0.0104
6 HYPERFERRITINAEMIA 3 0.0070
7 CREATININE RENAL CLEARANCE INCREASED 3 0.0040
8 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
9 BLOOD KETONE BODY 1 0.0029
10 ALBUMIN URINE PRESENT 1 0.0026
11 BLOOD URIC ACID DECREASED 1 0.0021
12 ROOT CANAL INFECTION 1 0.0020
13 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
14 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
15 MECHANICAL ILEUS 1 0.0018
16 SEDATION COMPLICATION 4 0.0016
17 SPUTUM ABNORMAL 1 0.0015
18 NEUROENDOCRINE TUMOUR 2 0.0014
19 BLISTER RUPTURE 1 0.0013
20 MULTIPLE DRUG THERAPY 1 0.0013
21 LINEAR IGA DISEASE 2 0.0012
22 IMMUNE-MEDIATED MYOSITIS 3 0.0011
23 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
24 SKIN OEDEMA 1 0.0010
25 BLAST CELL COUNT INCREASED 1 0.0010
26 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
27 METASTASES TO PLEURA 1 0.0010
28 INFUSION SITE MASS 1 0.0009
29 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
30 CORTISOL DECREASED 1 0.0009
31 METASTATIC MALIGNANT MELANOMA 2 0.0009
32 RESTRICTIVE PULMONARY DISEASE 1 0.0009
33 REFLUX GASTRITIS 1 0.0008
34 INVESTIGATION ABNORMAL 1 0.0007
35 GALLBLADDER CANCER 1 0.0007
36 IMPETIGO 1 0.0007
37 MEAN CELL VOLUME DECREASED 1 0.0006
38 RENAL FUNCTION TEST ABNORMAL 3 0.0006
39 BACTERIAL VAGINOSIS 1 0.0006
40 VASOPLEGIA SYNDROME 1 0.0006
41 INFUSION SITE DISCHARGE 1 0.0006
42 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
43 JOINT NOISE 1 0.0005
44 EMPYEMA 1 0.0005
45 LIMB MASS 1 0.0005
46 BACTERIAL TEST POSITIVE 1 0.0004
47 LOCALISED OEDEMA 2 0.0004
48 SINUS PAIN 1 0.0004
49 PULSE ABNORMAL 1 0.0004
50 PLATELET DISORDER 1 0.0004
51 METASTASES TO PERITONEUM 1 0.0004
52 DYSLIPIDAEMIA 2 0.0004
53 NOCARDIOSIS 1 0.0004
54 COMPARTMENT SYNDROME 1 0.0004
55 LUNG OPACITY 1 0.0004
56 BLOOD CALCIUM DECREASED 4 0.0004
57 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
58 BLOOD CREATININE DECREASED 1 0.0003
59 INFUSION SITE PRURITUS 1 0.0003
60 ABDOMINAL ADHESIONS 1 0.0003
61 NEPHRITIS 1 0.0003
62 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
63 MONOCYTE COUNT INCREASED 1 0.0003
64 BLINDNESS TRANSIENT 2 0.0003
65 HAEMODYNAMIC INSTABILITY 2 0.0003
66 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
67 POLYDIPSIA 1 0.0003
68 HYPERPHAGIA 1 0.0003
69 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
70 ORTHOSTATIC HYPOTENSION 4 0.0002
71 ILEUS PARALYTIC 1 0.0002
72 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
73 VAGINAL INFECTION 1 0.0002
74 COLITIS MICROSCOPIC 1 0.0002
75 NON-SMALL CELL LUNG CANCER 1 0.0002
76 SUBCUTANEOUS ABSCESS 1 0.0002
77 BLADDER DISORDER 2 0.0002
78 PROTEIN URINE PRESENT 1 0.0002
79 TEMPERATURE INTOLERANCE 2 0.0002
80 TONSILLITIS 1 0.0002
81 BLOOD LACTIC ACID INCREASED 1 0.0002
82 OVERWEIGHT 1 0.0002
83 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
84 SKIN WARM 1 0.0002
85 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
86 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
87 OLIGURIA 1 0.0002
88 SEDATION 4 0.0002
89 SEASONAL ALLERGY 2 0.0001
90 THERMAL BURN 1 0.0001
91 MOUTH HAEMORRHAGE 1 0.0001
92 PEMPHIGOID 1 0.0001
93 PELVIC FRACTURE 1 0.0001
94 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
95 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
96 FURUNCLE 1 0.0001
97 PNEUMOTHORAX 2 0.0001
98 BLOOD ALBUMIN DECREASED 1 0.0001
99 FRUSTRATION TOLERANCE DECREASED 1 0.0001
100 BLOOD POTASSIUM INCREASED 2 0.0001
101 ACUTE CORONARY SYNDROME 1 0.0001
102 HAEMODIALYSIS 1 0.0001
103 INFUSION SITE ERYTHEMA 1 0.0001
104 PYELONEPHRITIS 1 0.0001
105 ANGIOEDEMA 5 0.0001
106 OROPHARYNGEAL DISCOMFORT 1 0.0001
107 LIP DRY 1 0.0001
108 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
109 DEMENTIA 3 0.0001
110 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
111 NEUTROPHIL COUNT INCREASED 1 0.0001
112 INJECTION SITE DISCOMFORT 1 0.0001
113 METABOLIC ACIDOSIS 3 0.0001
114 SKIN LACERATION 1 0.0001
115 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
116 NEPHROPATHY TOXIC 1 0.0001
117 SCAB 1 0.0001
118 SHOCK 2 0.0001
119 RENAL DISORDER 4 0.0001
120 COGNITIVE DISORDER 4 0.0001
121 MUSCLE ATROPHY 1 0.0001
122 INTENTIONAL OVERDOSE 5 0.0001
123 PLATELET COUNT INCREASED 1 0.0001
124 ORAL CANDIDIASIS 1 0.0001
125 PERIPHERAL COLDNESS 1 0.0001
126 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
127 SINUS TACHYCARDIA 1 0.0001
128 MOBILITY DECREASED 5 0.0001
129 THYROID DISORDER 1 0.0001
130 BASAL CELL CARCINOMA 1 0.0001
131 RESPIRATORY TRACT CONGESTION 1 0.0001
132 OBESITY 1 0.0001
133 LACTIC ACIDOSIS 2 0.0001
134 METASTASES TO BONE 1 0.0001
135 MANIA 1 0.0001
136 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
137 BLOOD UREA INCREASED 1 0.0001
138 MUSCULOSKELETAL DISCOMFORT 1 0.0001
139 EOSINOPHILIA 1 0.0001
140 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
141 OSTEOMYELITIS 1 0.0001
142 AGRANULOCYTOSIS 1 0.0001
143 BACTERIAL INFECTION 1 0.0001
144 HEPATIC FUNCTION ABNORMAL 2 0.0001
145 PHOTOPHOBIA 1 0.0001
146 GASTRIC ULCER 1 0.0001
147 PROTEINURIA 1 0.0001
148 MUSCULOSKELETAL DISORDER 1 0.0001
149 SLEEP APNOEA SYNDROME 1 0.0001
150 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
151 GLAUCOMA 1 0.0001
152 EAR PAIN 1 0.0001
153 ORAL HERPES 1 0.0001
154 BLOOD PRESSURE ABNORMAL 1 0.0001
155 CYTOKINE RELEASE SYNDROME 1 0.0000
156 CARDIAC FAILURE 4 0.0000
157 SUICIDE ATTEMPT 3 0.0000
158 VERTIGO 3 0.0000
159 BODY TEMPERATURE INCREASED 1 0.0000
160 PULMONARY HYPERTENSION 1 0.0000
161 POLLAKIURIA 2 0.0000
162 DERMATITIS 1 0.0000
163 TOXICITY TO VARIOUS AGENTS 8 0.0000
164 OSTEOARTHRITIS 2 0.0000
165 RHINORRHOEA 3 0.0000
166 BALANCE DISORDER 4 0.0000
167 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
168 BLOOD CREATININE INCREASED 3 0.0000
169 FEBRILE NEUTROPENIA 3 0.0000
170 PERICARDIAL EFFUSION 1 0.0000
171 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
172 BLOOD PRESSURE FLUCTUATION 1 0.0000
173 CONSTIPATION 9 0.0000
174 HYPOGLYCAEMIA 2 0.0000
175 CELLULITIS 2 0.0000
176 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
177 BLOOD PRESSURE INCREASED 6 0.0000
178 PALLOR 1 0.0000
179 DRUG ABUSE 3 0.0000
180 FEELING COLD 1 0.0000
181 OXYGEN SATURATION DECREASED 2 0.0000
182 EYE PAIN 2 0.0000
183 RED BLOOD CELL COUNT DECREASED 1 0.0000
184 ANGINA PECTORIS 1 0.0000
185 HYPOTENSION 7 0.0000
186 NEEDLE ISSUE 1 0.0000
187 ACUTE MYOCARDIAL INFARCTION 1 0.0000
188 PSYCHOTIC DISORDER 1 0.0000
189 BLOOD POTASSIUM DECREASED 1 0.0000
190 DISCOMFORT 2 0.0000
191 SWOLLEN TONGUE 1 0.0000
192 DRUG-INDUCED LIVER INJURY 1 0.0000
193 NIGHT SWEATS 1 0.0000
194 HEART RATE INCREASED 3 0.0000
195 BLOOD PRESSURE DECREASED 2 0.0000
196 FUNGAL INFECTION 1 0.0000
197 SKIN DISORDER 1 0.0000
198 GAIT INABILITY 1 0.0000
199 EYE PRURITUS 1 0.0000
200 HYPERKALAEMIA 1 0.0000
201 C-REACTIVE PROTEIN INCREASED 1 0.0000
202 HYPERGLYCAEMIA 1 0.0000
203 ACCIDENTAL OVERDOSE 1 0.0000
204 BRONCHITIS 2 0.0000
205 DYSPNOEA EXERTIONAL 1 0.0000
206 HOT FLUSH 2 0.0000
207 INJECTION SITE SWELLING 2 0.0000
208 OEDEMA PERIPHERAL 3 0.0000
209 DYSKINESIA 1 0.0000
210 SEPTIC SHOCK 1 0.0000
211 LIVER DISORDER 1 0.0000
212 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
213 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
214 THROAT IRRITATION 1 0.0000
215 ADVERSE DRUG REACTION 2 0.0000
216 VISION BLURRED 3 0.0000
217 NEPHROLITHIASIS 1 0.0000
218 OROPHARYNGEAL PAIN 2 0.0000
219 DECREASED APPETITE 5 0.0000
220 COUGH 6 0.0000
221 NEUROPATHY PERIPHERAL 2 0.0000
222 PRODUCTIVE COUGH 1 0.0000
223 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
224 DYSPEPSIA 2 0.0000
225 FLUID RETENTION 1 0.0000
226 ACUTE KIDNEY INJURY 3 0.0000
227 CHEST DISCOMFORT 2 0.0000
228 SINUSITIS 2 0.0000
229 HAEMOGLOBIN DECREASED 2 0.0000
230 DYSPNOEA 11 0.0000
231 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
232 SPEECH DISORDER 1 0.0000
233 DRUG INTERACTION 3 0.0000
234 BRADYCARDIA 1 0.0000
235 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
236 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
237 FALL 6 0.0000
238 ARTHROPATHY 1 0.0000
239 SEPSIS 2 0.0000
240 NECK PAIN 1 0.0000
241 BLISTER 1 0.0000
242 LETHARGY 1 0.0000
243 DYSPHONIA 1 0.0000
244 SURGERY 1 0.0000
245 BLADDER CANCER 1 0.0000
246 WHEEZING 1 0.0000
247 CATARACT 1 0.0000
248 THERAPEUTIC RESPONSE DECREASED 1 0.0000
249 PLEURAL EFFUSION 1 0.0000
250 FEELING HOT 1 0.0000
251 NASOPHARYNGITIS 3 0.0000
252 RASH 7 0.0000
253 GAIT DISTURBANCE 3 0.0000
254 LOSS OF CONSCIOUSNESS 2 0.0000
255 HYPERHIDROSIS 2 0.0000
256 AMNESIA 1 0.0000
257 PSORIASIS 2 0.0000
258 INFUSION RELATED REACTION 1 0.0000
259 DEHYDRATION 2 0.0000
260 MEMORY IMPAIRMENT 2 0.0000
261 HYPERTENSION 3 0.0000
262 SKIN BURNING SENSATION 1 0.0000
263 OVERDOSE 3 0.0000
264 DIABETES MELLITUS 1 0.0000
265 ABDOMINAL PAIN 3 0.0000
266 PROSTATE CANCER 1 0.0000
267 DRY MOUTH 1 0.0000
268 INFLUENZA LIKE ILLNESS 1 0.0000
269 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
270 RENAL IMPAIRMENT 1 0.0000
271 MUSCULOSKELETAL STIFFNESS 1 0.0000
272 COVID-19 2 0.0000
273 TACHYCARDIA 1 0.0000
274 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
275 SUICIDAL IDEATION 1 0.0000
276 VOMITING 5 0.0000
277 DYSPHAGIA 1 0.0000
278 PULMONARY EMBOLISM 1 0.0000
279 ANAEMIA 2 0.0000
280 MIGRAINE 1 0.0000
281 CONTUSION 1 0.0000
282 ATRIAL FIBRILLATION 1 0.0000
283 SYNCOPE 1 0.0000
284 SOMNOLENCE 2 0.0000
285 PAIN 6 0.0000
286 ARTHRALGIA 4 0.0000
287 PLATELET COUNT DECREASED 1 0.0000
288 DIARRHOEA 6 0.0000
289 PNEUMONIA 3 0.0000
290 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
291 INFLUENZA 1 0.0000
292 RHEUMATOID ARTHRITIS 1 0.0000
293 MUSCULAR WEAKNESS 1 0.0000
294 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
295 BACK PAIN 2 0.0000
296 CHILLS 1 0.0000
297 VISUAL IMPAIRMENT 1 0.0000
298 INJECTION SITE ERYTHEMA 1 0.0000
299 PRURITUS 3 0.0000
300 WEIGHT DECREASED 2 0.0000
301 PRODUCT DOSE OMISSION ISSUE 2 0.0000
302 PAIN IN EXTREMITY 2 0.0000
303 HYPOAESTHESIA 1 0.0000
304 CONDITION AGGRAVATED 2 0.0000
305 HOSPITALISATION 1 0.0000
306 PERIPHERAL SWELLING 1 0.0000
307 HEADACHE 4 0.0000
308 PARAESTHESIA 1 0.0000
309 CONFUSIONAL STATE 1 0.0000
310 CEREBROVASCULAR ACCIDENT 1 0.0000
311 MYALGIA 1 0.0000
312 URINARY TRACT INFECTION 1 0.0000
313 PYREXIA 2 0.0000
314 OFF LABEL USE 5 0.0000
315 MUSCLE SPASMS 1 0.0000
316 CHEST PAIN 1 0.0000
317 HYPERSENSITIVITY 1 0.0000
318 PRODUCT USE ISSUE 1 0.0000
319 ASTHENIA 2 0.0000
320 BLOOD GLUCOSE INCREASED 1 0.0000
321 FATIGUE 4 0.0000
322 NAUSEA 4 0.0000
323 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
324 ERYTHEMA 1 0.0000
325 MALAISE 2 0.0000
326 WEIGHT INCREASED 1 0.0000
327 DEPRESSION 1 0.0000
328 FEELING ABNORMAL 1 0.0000
329 DIZZINESS 2 0.0000
330 ANXIETY 1 0.0000
331 INJECTION SITE PAIN 1 0.0000
332 DRUG INEFFECTIVE 4 0.0000